No good news and no new buyers and no partners and delays compounding delays No faith in company, poor management and do I need go on. Selling a few thousand shares sends stock plummeting. Great disappointment here in Nymox land. CEO needs to make company perform. Could be good entry opportunity but unfortunately all the cheerleadiing in the world needs to have some results other than extensions and excuses. Eventually reality bites. A lot of great ideas fail because of porr execution. Recordati could release more than cursory statements and Nymox could release some statements regarding the science of their treatment. Not looking good presently.
Recordati is not going to do anything. For whatever money they paid they have a call option on the drug. If the phase three trials are successfull then they wil do something otherwise goodbye. The company is also not going to do anything even if they want to what are they going to do? Unfortunately it looks like this stock is going lower as some major holder is dumping.